UKRI Strategic Delivery Plan

UKRI Strategic Delivery Plan
Name	UKRI Strategic Delivery Plan
Founded	2018
Jurisdiction	United Kingdom

Contents

UKRI Strategic Delivery Plan The UKRI Strategic Delivery Plan is a policy framework guiding Science and Technology Facilities Council and Engineering and Physical Sciences Research Council priorities across the United Kingdom, aligning activities with statutory drivers such as the Higher Education and Research Act 2017 and international commitments like the Horizon Europe association discussions. It synthesises strategic aims drawn from white papers including the Industrial Strategy and links to institutional roadmaps produced by bodies such as the Royal Society and the British Academy. The Plan frames investment, governance and impact measures alongside sectoral strategies like those advanced by the Medical Research Council, Arts and Humanities Research Council and Innovate UK.

Overview

The Overview situates the Plan within the broader landscape shaped by the Department for Business, Energy and Industrial Strategy, the National Audit Office scrutiny regime and advisory inputs from the Science and Technology Committee. It references foundational documents such as the Research Excellence Framework and the Winton Programme for the Physics of Sustainability to contextualise priorities, while acknowledging regional strategies by the Scottish Government, the Welsh Government and the Northern Ireland Executive. The section clarifies remit overlap with the European Research Council negotiations and coordination with the University Alliance, Russell Group and GuildHE to ensure cohesion.

This section articulates priorities including translational research linking the Medical Research Council with the National Institute for Health and Care Research, innovation programmes coordinated with Innovate UK and capability building supporting the UK Space Agency and the Met Office. Objectives draw on thematic agendas such as net zero targets embodied in the Climate Change Act 2008, industrial decarbonisation roadmaps by the Committee on Climate Change and skills investments resonant with the Augar Review. The Plan commits to cross-cutting aims echoed by the Royal Society of Chemistry, the Biotechnology and Biological Sciences Research Council and the Turing Institute to accelerate translational pipelines and strengthen resilience in the face of strategic shocks like those considered by the National Security Council.

Implementation aligns delivery mechanisms with organisational structures including the UK Research and Innovation Chief Executive Office, Boards modelled on precedents from the Wellcome Trust and oversight practices used by the National Institute for Health and Care Excellence. Governance draws on assurance approaches exemplified by the Crown Commercial Service and reporting frameworks similar to those applied by the Arts Council England. Delivery roles are coordinated with sector regulators such as the Office for Students and statutory partners like the Medical and Healthcare products Regulatory Agency, while institutional compliance references structures used by the Chartered Institute of Personnel and Development.

Funding arrangements reference allocations comparable to those negotiated within the Spending Review and multiyear settlements like the Comprehensive Spending Review 2021. Resource allocation mechanisms mirror competitive funding models used by the Engineering and Physical Sciences Research Council and portfolio management approaches influenced by the Leverhulme Trust and the Royal Society. The Plan sets priorities for capital programmes similar to those for the Diamond Light Source and infrastructure investments akin to the National Graphene Institute, and funds translational consortia connecting the Francis Crick Institute and the Health Data Research UK.

Performance frameworks draw on metrics employed by the Research Excellence Framework and evaluation methods developed by the Economic and Social Research Council and the Office for National Statistics. Monitoring uses indicators comparable to those adopted by the International Monetary Fund for project appraisal and follows audit trails similar to National Audit Office practice. Evaluation cycles coordinate with review panels influenced by the Royal Society International Exchange Scheme and impact case studies modelled on submissions to the Higher Education Funding Council for England.

Stakeholder strategies cultivate partnerships with sectoral actors including the Tech Nation network, industrial partners such as Rolls-Royce and AstraZeneca, and civic bodies like the Local Government Association. The Plan embeds collaboration with learned societies including the Institute of Physics, professional bodies such as the British Medical Association and funders like the Wellcome Trust and Gatsby Charitable Foundation. International collaboration references memoranda with the National Science Foundation and bilateral arrangements akin to those between the UK and the United States scientific communities through institutions such as the Royal Society and the Academy of Medical Sciences.

Expected outcomes cite enhanced capability across research domains represented by the Biotechnology and Biological Sciences Research Council, increased commercialisation trajectories similar to Catapult centres outputs, and societal benefits aligned with priorities of the National Health Service and the Department for Environment, Food and Rural Affairs. Impact narratives reference precedent cases such as translational successes at the Francis Crick Institute and technology spin-outs comparable to firms incubated by the Sanger Institute. The Plan projects long-term returns comparable to modeling by the Office for Budget Responsibility and strategic risk mitigation informed by the National Security Strategy.

Category:United Kingdom research policy